Kenmore, Australia

Avril Robertson

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Avril Robertson: Innovator in Pharmaceutical Compounds

Introduction

Avril Robertson is a notable inventor based in Kenmore, Australia, recognized for his contributions to the field of pharmaceutical compounds. With a total of four patents to his name, he has made significant strides in developing innovative treatments for various medical disorders.

Latest Patents

Robertson's latest patents include groundbreaking work on sulfonylureas and related compounds. His inventions focus on compounds that have potential applications in treating NLRP3 inflammasome mediated disorders. The patents detail the chemical structures and formulations of these compounds, emphasizing their pharmaceutical compositions and methods of treatment. These innovations aim to enhance insulin secretion while inhibiting NLRP3, showcasing a dual action that could revolutionize treatment approaches.

Career Highlights

Throughout his career, Avril Robertson has worked with esteemed institutions such as the University of Queensland. His research has contributed to advancements in the pharmaceutical industry, particularly in the development of compounds that address critical health issues.

Collaborations

Robertson has collaborated with notable figures in the field, including Luke O'Neill and Rebecca Coll. These partnerships have fostered a collaborative environment that enhances the research and development of innovative medical solutions.

Conclusion

Avril Robertson's work exemplifies the spirit of innovation in the pharmaceutical sector. His patents and collaborations reflect a commitment to improving health outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…